Ignite Creation Date:
2025-12-24 @ 7:08 PM
Ignite Modification Date:
2025-12-29 @ 1:14 AM
Study NCT ID:
NCT02008357
Status:
COMPLETED
Last Update Posted:
2023-12-28
First Post:
2013-12-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-02-28
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-06-08
Completion Date Type:
ACTUAL
First Submit Date:
2013-12-06
First Submit QC Date:
None
Study First Post Date:
2013-12-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-12-14
Results First Submit QC Date:
None
Results First Post Date:
2023-12-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-14
Last Update Post Date:
2023-12-28
Last Update Post Date Type:
ACTUAL